{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:20:21Z","timestamp":1793881221324,"version":"4.7.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtha.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:39:53Z","timestamp":1692704393000},"page":"3649-3657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4766-3314","authenticated-orcid":false,"given":"Roman M.","family":"Sniecinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-6423","authenticated-orcid":false,"given":"Bianca","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-7541","authenticated-orcid":false,"given":"Kamrouz","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0394","authenticated-orcid":false,"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-4732","authenticated-orcid":false,"given":"Corinne","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-6403","authenticated-orcid":false,"given":"Andreas","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1186-7808","authenticated-orcid":false,"given":"Tara K.","family":"Lech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-2674","authenticated-orcid":false,"given":"Cheryl L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6025-1379","authenticated-orcid":false,"given":"Mathew D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-3623","authenticated-orcid":false,"given":"Ecatarina","family":"Scarlestscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-461X","authenticated-orcid":false,"given":"Alex","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-1920","authenticated-orcid":false,"given":"Marie E.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0179-1903","authenticated-orcid":false,"given":"Alfonso J.","family":"Tafur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1365","authenticated-orcid":false,"given":"Kenichi A.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.08.013_bib1","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/acs.chemrev.1c00118","article-title":"Introduction: drug resistance","volume":"121","author":"Yilmaz","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtha.2023.08.013_bib2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib3","article-title":"Coagulation time of blood heparinized in\u00a0vitro: correlation of results with those of the heparin tolerance test","volume":"32","author":"Hagedorn","year":"1947","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib4","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.08.013_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","article-title":"A\u00a0randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin","volume":"154","author":"Levine","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.08.013_bib7","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.08.013_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0038-1648515","article-title":"Heparin binding to plasma proteins, an important mechanism for heparin resistance","volume":"67","author":"Young","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.08.013_bib9","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/PCC.0b013e31827200b6","article-title":"Bivalirudin in pediatric patients maintained on extracorporeal life support","volume":"14","author":"Nagle","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0034-1398382","article-title":"Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis","volume":"41","author":"Treichl","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.08.013_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PCC.0000000000000278","article-title":"The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life","volume":"16","author":"Northrop","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib12","first-page":"170","article-title":"Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy","volume":"35","author":"Gionis","year":"2016","journal-title":"Int Angiol"},{"key":"10.1016\/j.jtha.2023.08.013_bib13","article-title":"A\u00a0prospective pilot trial to assess the efficacy of argatroban (Argatra\u00ae) in critically ill patients with heparin resistance","volume":"9","author":"Bachler","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ijlh.13230","article-title":"Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2","volume":"42","author":"Beun","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.08.013_bib15","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1055\/s-0040-1719083","article-title":"Monitoring of unfractionated heparin in severe COVID-19: an observational study of patients on CRRT and ECMO","volume":"4","author":"Streng","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2023.08.013_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.08.013_bib17","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","article-title":"A\u00a0randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation","volume":"48","author":"Panigada","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkab032","article-title":"Heparin resistance in severe thermal injury: a prospective cohort study","volume":"9","author":"Cato","year":"2021","journal-title":"Burns Trauma"},{"key":"10.1016\/j.jtha.2023.08.013_bib19","first-page":"10","article-title":"Decreased CRRT filter lifespan in COVID-19 ICU patients","author":"Legouis","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/ijlh.13543","article-title":"Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit","volume":"43","author":"Novelli","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.08.013_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/MAT.0000000000001334","article-title":"Heparin resistance is common in patients undergoing extracorporeal membrane oxygenation but is not associated with worse clinical outcomes","volume":"67","author":"Raghunathan","year":"2021","journal-title":"Asaio J"},{"key":"10.1016\/j.jtha.2023.08.013_bib22","article-title":"Argatroban for anticoagulation in patients requiring venovenous extracorporeal membrane oxygenation in coronavirus disease 2019","volume":"3","author":"Sattler","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jtha.2023.08.013_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11239-021-02615-z","article-title":"Evaluation of heparin infusion rates in patients with intravenous drug misuse","volume":"53","author":"Barga","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.08.013_bib24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1055\/s-0042-1756304","article-title":"Low-molecular-weight heparin resistance and its viscoelastic assessment in critically ill COVID-19 patients","volume":"48","author":"B\u00f6sch","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.08.013_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/00185787221111743","article-title":"Heparin resistance in SARS-CoV-2 infected patients with venous thromboembolism","volume":"57","author":"Chau","year":"2022","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.jtha.2023.08.013_bib26","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/bcp.15703","article-title":"Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation","volume":"89","author":"Procaccini","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2023.08.013_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1309\/AJCPS6OW6DYNOGNH","article-title":"Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance","volume":"139","author":"Takemoto","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2023.08.013_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1076029617741363","article-title":"Performance of anti-factor Xa versus activated partial thromboplastin time for heparin monitoring using multiple nomograms","volume":"24","author":"Whitman-Purves","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.08.013_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"Price","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtha.2023.08.013_bib30","first-page":"1290","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"379","author":"Garcia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.08.013_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623006414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623006414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:44Z","timestamp":1761536384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623006414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1538783623006414"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.08.013","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}